Interplay between caveolin-1 and mineralocorticoid receptor in cardiometabolic disease
Journal of Endocrinology · 2024
DOI: 10.1530/joe-23-0341 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Endocrinology, 2024. Verfasst von Katarzyna Czarzasta und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental and Clinical Physiology, Laboratory of Center for Preclinical Research, Medical University of Warsaw, Warszawa, Poland. Hauptthemen laut MEDLINE: Caveolin 1, Receptors, Mineralocorticoid, Cardiovascular Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 147 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.
Abstract (Originalsprache)
Over the past decades, research has clearly established the important role of the mineralocorticoid receptor (MR) in both renal and extra-renal tissues. Recently, caveolin-1 (Cav-1) has emerged as a mediator of MR signaling in several tissues, with implications on cardiovascular and metabolic dysfunction. The main structural component of caveolae (plasma membrane invaginations with diverse functions), Cav-1 is a modulator of cardiovascular function, cellular glucose, and lipid homeostasis, via its effects on signal transduction pathways that mediate inflammatory responses and oxidative stress. In this review, we present evidence indicating an overlap between the roles of the MR and Cav-1 in cardiometabolic disease and the relevant signaling pathways involved. Furthermore, we discuss the potential use of Cav-1 as a biomarker and/or target for MR-mediated dysfunction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Experimental and Clinical Physiology, Laboratory of Center for Preclinical Research, Medical University of Warsaw, Warszawa, Poland.
- Division of Endocrinology, Diabetes and Hypertension, Department of Medicine, Brigham and Women's Hospital/Harvard Medical School, Boston, Massachusetts, USA.
ORCID-Profile: Luminita H Pojoga
Förderung
- NHLBI NIH HHS
Zitieren
APA
Czarzasta, K., & Pojoga, L. H. (2024). Interplay between caveolin-1 and mineralocorticoid receptor in cardiometabolic disease. Journal of Endocrinology. https://doi.org/10.1530/joe-23-0341
Vancouver
Czarzasta K, Pojoga LH. Interplay between caveolin-1 and mineralocorticoid receptor in cardiometabolic disease. Journal of Endocrinology. 2024. doi:10.1530/joe-23-0341
BibTeX
@article{Czarzasta2024,
author = {Czarzasta, Katarzyna and Pojoga, Luminita H},
title = {Interplay between caveolin-1 and mineralocorticoid receptor in cardiometabolic disease},
journal = {Journal of Endocrinology},
year = {2024},
doi = {10.1530/joe-23-0341}
}
EUVIMED